Tag archief: English Only

Boehringer Ingelheim R&D Pushes to Transcend Disease Boundaries

  INGELHEIM, Germany–(BUSINESS WIRE)– Family-owned pharmaceutical company Boehringer Ingelheim today presented its latest pipeline updates at a Research & Development press conference entitled ‘Transcending Disease...

New Analyses from Pivotal Phase III Trials of Oral Ozanimod in Relapsing Multiple Sclerosis To Be Presented at the 2018 American Academy of Neurology Annual Meeting

SUMMIT, N.J.–(BUSINESS WIRE)– Celgene Corporation (NASDAQ:CELG) today announced additional phase III data analyses evaluating the efficacy and safety of ozanimod, a novel, oral, selective sphingosine 1-phosphate...

First-Quarter Figures: Sartorius Starts off Fiscal 2018 Successfully

GOTTINGEN, Germany–(BUSINESS WIRE)– Sartorius, a leading international partner of the biopharmaceutical industry and the research sector, looks back on a successful first quarter 2018. “Both...

The Digital Classroom: Gemalto Helps Casio to Bring Education into the 21st Century

AMSTERDAM–(BUSINESS WIRE)– Gemalto, the world leader in digital security, can today reveal that it has partnered with Casio, one of the world’s leading manufacturers of...

ABB and the Economist Launch Automation Readiness Index, Global Ranking for Robotics and Artificial Intelligence (Document: Business Wire)

ZURICH–(BUSINESS WIRE)– South Korea, Germany and Singapore are the world’s top-ranked nations in their preparations for smoothly integrating intelligent automation into their economies, according to...

New SPINRAZA® (nusinersen) Data Unveiled at AAN Annual Meeting Show Continued Improvement in Motor Function for Broad Age Range and Survival Benefit for Infants

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Biogen (Nasdaq: BIIB) today announced new findings detailing the benefits that SPINRAZA® (nusinersen) demonstrates for both infantile- and later-onset spinal muscular atrophy...

Country Leaders Inspired by ABB’s Breakthrough E-Mobility Technologies

HANNOVER, Germany–(BUSINESS WIRE)– The two leaders, along with ABB CEO Ulrich Spiesshofer, were shown a demonstration of the company’s new high power fast charging solution:...

Gemalto Awarded Multi-Year Service Contract for New British Passports

LONDON–(BUSINESS WIRE)– Gemalto, the world leader in digital security, today announces it has won an open tender with the Home Office, acting through Her Majesty’s...

ABB Showcases World-Leading e-Vehicle Fast Chargers and Launches AI Readiness Index at Hannover

HANNOVER, Germany–(BUSINESS WIRE)– ABB spotlighted its world-leading Terra HP family of fast chargers for electric vehicles at Hannover Messe, the biggest global industrial trade fair....

Biogen and Ionis Expand Strategic Collaboration to Develop Drug Candidates for a Broad Range of Neurological Diseases

CAMBRIDGE, Mass. & CARLSBAD, Calif.–(BUSINESS WIRE)– Biogen (Nasdaq: BIIB) and Ionis Pharmaceuticals (Nasdaq: IONS) announced today they have expanded their strategic collaboration through a new ten-year collaboration...

QIAGEN posts 2017 Annual Report on Its website

VENLO, the Netherlands–(BUSINESS WIRE)– QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) announced today that has posted its 2017 Annual Report on its website at...

Nexperia Secures $800M Financing to Fund Future Growth Plans

NIJMEGEN, Netherlands–(BUSINESS WIRE)– Nexperia, the global leader in discretes, logic and MOSFET devices, today announced the successful completion of a refinancing of its current facilities...

ABB: Profitable Growth

ZURICH–(BUSINESS WIRE)– ABB (SWX:ABBN): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180418006701/en/ “We started 2018 with order growth in all divisions, improved...

bluebird bio Announces New England Journal of Medicine Publication of Interim Data from Two Phase 1/2 Clinical Studies of LentiGlobinTM Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

CAMBRIDGE, Mass.–(BUSINESS WIRE)– bluebird bio, Inc. (Nasdaq: BLUE) today announced interim data published in the New England Journal of Medicine (NEJM) from two separate two-year...

Debiopharm International SA Strengthens Compliance and Clinical Trial Oversight with Veeva Vault eTMF

BARCELONA, Spain–(BUSINESS WIRE)– Veeva Systems (NYSE: VEEV) announced today that Debiopharm International SA, part of Swiss-based biopharmaceutical company Debiopharm Group™, selected Veeva Vault eTMF to improve oversight across its trial...